PINDOLOL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pindolol, and what generic alternatives are available?
Pindolol is a drug marketed by Ani Pharms, Aurobindo Pharma Usa, Bayshore Pharms Llc, Cosette, Mylan Pharms Inc, Nostrum Labs, Nostrum Labs Inc, Purepac Pharm, Sun Pharm Industries, Watson Labs, and Zydus Pharms. and is included in fourteen NDAs.
The generic ingredient in PINDOLOL is pindolol. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pindolol profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Pindolol
A generic version of PINDOLOL was approved as pindolol by AUROBINDO PHARMA USA on September 3rd, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PINDOLOL?
- What are the global sales for PINDOLOL?
- What is Average Wholesale Price for PINDOLOL?
Summary for PINDOLOL
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 14 |
| Finished Product Suppliers / Packagers: | 9 |
| Raw Ingredient (Bulk) Api Vendors: | 78 |
| Clinical Trials: | 17 |
| Patent Applications: | 4,279 |
| Drug Prices: | Drug price information for PINDOLOL |
| DailyMed Link: | PINDOLOL at DailyMed |
Recent Clinical Trials for PINDOLOL
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Scotmann Pharmaceuticals | Phase 3 |
| Rawalpindi Medical College | Phase 3 |
| Quotient Sciences | Phase 1 |
Pharmacology for PINDOLOL
| Drug Class | beta-Adrenergic Blocker |
| Mechanism of Action | Adrenergic beta-Antagonists |
Medical Subject Heading (MeSH) Categories for PINDOLOL
Anatomical Therapeutic Chemical (ATC) Classes for PINDOLOL
US Patents and Regulatory Information for PINDOLOL
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ani Pharms | PINDOLOL | pindolol | TABLET;ORAL | 073609-002 | Mar 29, 1993 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Nostrum Labs Inc | PINDOLOL | pindolol | TABLET;ORAL | 205415-002 | Jan 13, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | PINDOLOL | pindolol | TABLET;ORAL | 074437-002 | Feb 27, 1995 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
